The link between aspirin, bowel cancer and our genes
27 March, 2015An international research team has suggested that the ingestion of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs), long associated with lowering the risk of bowel (colorectal) cancer, may be dependent on a person's individual genetics.
The link between aspirin, bowel cancer and our genes
27 March, 2015An international research team has suggested that the ingestion of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs), long associated with lowering the risk of bowel (colorectal) cancer, may be dependent on a person's individual genetics.
Corning mini bioreactor and 5 L Erlenmeyer flask
25 March, 2015 | Supplied by: Corning Incorporated Life Sciences
Corning has released a mini bioreactor and 5 L Erlenmeyer flask, expanding the company's product range for suspension cell culture.
Tracing the spread of drug-resistant TB
25 March, 2015An international research team has, for the first time, used DNA sequencing to trace the fatal spread of multidrug-resistant tuberculosis (TB) between patients in the UK.
Thermo Fisher Scientific Oncomine Solid Tumour Fusion Transcript kit
24 March, 2015 | Supplied by: Thermo Fisher ScientificThermo Fisher Scientific has released its CE-IVD Oncomine Solid Tumour Fusion Transcript kit for next-generation sequencing (NGS), designed to aid clinical decision-making and enable multiplexed sequencing of formalin-fixed, paraffin-embedded (FFPE) tumour samples.
Promega PowerQuant System PCR method
23 March, 2015 | Supplied by: Promega Pty LtdPromega’s PowerQuant System is a probe-based, 4-target, 5-dye real-time PCR method. The system allows laboratories to determine human and male DNA concentrations in a sample, assess the integrity of the DNA sample and detect possible PCR inhibitors in approximately 1 h.
Microcalorimetry assay opens new research avenues
23 March, 2015 | Supplied by: SymCelAssay developer SymCel has announced the publication of positive scientific data on its microcalimeter technology calScreener - said to be the first multichannel calorimetric system specifically developed for cell-based assays.
GeneCopoeia Luc-Pair Luciferase Assay 2.0 Kit
20 March, 2015 | Supplied by: United Bioresearch Products Pty LtdThe Luc-Pair Luciferase Assay Kit 2.0 kit is optimised for long-range linearity of both firefly and Renilla luciferase signals. It is suitable for studying the interaction between precursor miRNA clones and miTarget 3'UTR target clones.
Explaining malaria protection in blood type O
19 March, 2015Scientists from Sweden's Karolinska Institutet have explained the mysterious mechanism which protects people with blood type O from dying of severe malaria.
MERLIN MICRONAUT-AM plates (EUCAST)
19 March, 2015 | Supplied by: Dutec Diagnostics Pty LtdSusceptibility testing with MERLIN MICRONAUT-AM plates (EUCAST) is based on the rehydration of antimycotics by adding a standardised yeast suspension. Growth of the yeasts is indicated by a colour change from blue to pink mediated by the AST indicator supplementing the test medium.
Explaining malaria protection in blood type O
19 March, 2015Scientists from Sweden's Karolinska Institutet have explained the mysterious mechanism which protects people with blood type O from dying of severe malaria.
ToolGen licenses CRISPR/Cas9 technology to Thermo Fisher Scientific
16 March, 2015Korean biotechnology company ToolGen will license its CRISPR/Cas9 intellectual property portfolio to Thermo Fisher Scientific. Thermo Fisher will utilise the technology to develop and market CRISPR reagent kits.
BeiGene chooses CHOZN for oncology drug development
16 March, 2015 | Supplied by: MerckOncology company BeiGene has purchased SAFC's off-the-shelf, turnkey CHOZN cell line production platform and cell line engineering services to support discovery and commercial development of BeiGene's targeted oncology drug.
ToolGen licenses CRISPR/Cas9 technology to Thermo Fisher Scientific
16 March, 2015Korean biotechnology company ToolGen will license its CRISPR/Cas9 intellectual property portfolio to Thermo Fisher Scientific. Thermo Fisher will utilise the technology to develop and market CRISPR reagent kits.
Single donor's blood cells to test side effects of drugs
11 March, 2015UK researchers are using combinations of cells from a single donor's blood to predict whether a new drug will cause a severe immune reaction in humans.
